Showing results (91-100 of 127) with videos related to
Sort By:
Pageof 13
International Journal of Hematology|December 13, 2025
Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemiaKohjin Suzuki, Tomoiku Takaku, Naoki Watanabe, et al.American Journal of Hematology|January 20, 2017
Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemiaShin Fujisawa, Shuichi Mizuta, Hideki Akiyama, et al.International Journal of Hematology|May 2, 2023
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effectsMichihide Tokuhira, Yuta Kimura, Takayuki Tabayashi, et al.International Journal of Hematology|June 23, 2011
An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphomaKatsuhiro Miura, Kazuhiro Takei, Sumiko Kobayashi, et al.Medical Oncology (Northwood, London, England)|May 31, 2018
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitorsTomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, et al.Experimental and Therapeutic Medicine|September 13, 2012
Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOPYujin Kobayashi, Yoshihiro Hatta, Atsuko Hojo, et al.Leukemia Research|July 2, 2013
CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21)Noriyoshi Iriyama, Yoshihiro Hatta, Jin Takeuchi, et al.Journal of Clinical and Experimental Hematopathology : JCEH|December 16, 2014
Efficacy of molecular response at 1 or 3 months after the initiation of dasatinib treatment can predict an improved response to dasatinib in imatinib-resistant or imatinib-intolerant Japanese patients with chronic myelogenous leukemia during the chronic phaseKoiti Inokuchi, Takashi Kumagai, Eri Matsuki, et al.British Journal of Haematology|February 2, 2013
Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemiaShinichi Kako, Heiwa Kanamori, Naoki Kobayashi, et al.Annals of Medicine|April 29, 2022
Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitorsYuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, et al.Pageof 13